Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury

The beneficial effects of mineralocorticoid receptor (MR) antagonists (MRAs) for various kidney diseases are established. However, the underlying mechanisms of kidney injury induced by MR activation remain to be elucidated. We recently reported aldosterone-induced enhancement of proteoglycan express...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Toshifumi, Bonnard, Benjamin, Palacios-Ramirez, Roberto, Fernández-Celis, Amaya, Jaisser, Frédéric, López-Andrés, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224513/
https://www.ncbi.nlm.nih.gov/pubmed/35743123
http://dx.doi.org/10.3390/ijms23126680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224513/
https://www.ncbi.nlm.nih.gov/pubmed/35743123
http://dx.doi.org/10.3390/ijms23126680

Ejemplares similares